1. Home
  2. CRDO vs TECH Comparison

CRDO vs TECH Comparison

Compare CRDO & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$96.78

Market Cap

20.3B

Sector

Technology

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$53.45

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
TECH
Founded
2008
1976
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3B
10.2B
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
CRDO
TECH
Price
$96.78
$53.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
12
Target Price
$176.36
$73.09
AVG Volume (30 Days)
6.7M
2.1M
Earning Date
03-02-2026
05-06-2026
Dividend Yield
N/A
0.61%
EPS Growth
261.11
N/A
EPS
1.62
0.49
Revenue
$436,775,000.00
$1,219,635,000.00
Revenue This Year
$210.92
$2.49
Revenue Next Year
$52.72
$6.40
P/E Ratio
$57.98
$106.41
Revenue Growth
126.34
5.23
52 Week Low
$29.09
$46.02
52 Week High
$213.80
$72.16

Technical Indicators

Market Signals
Indicator
CRDO
TECH
Relative Strength Index (RSI) 41.84 47.51
Support Level $91.74 $49.30
Resistance Level $104.35 $58.88
Average True Range (ATR) 7.41 1.98
MACD -0.75 0.52
Stochastic Oscillator 24.68 96.10

Price Performance

Historical Comparison
CRDO
TECH

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: